EVO Company Profile and Key Details
Evotec SE
EVO Stock Price Chart
Stock Price Today
Evotec SE (EVO) stock remained unchanged at $4.13 a share on NASDAQ. The stock opened at $4.17, fluctuating between $4.13 to $4.19 during the session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Company Information
| Employees | 5007 |
| Beta | 0.98 |
| Sales or Revenue | $781.43M |
| 5Y Sales Change% | 0.735% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Evotec SE (NASDAQ: EVO) stock price is $4.13 in the last trading session. During the trading session, EVO stock reached the peak price of $4.19 while $4.13 was the lowest point it dropped to. The percentage change in EVO stock occurred in the recent session was 0% while the dollar amount for the price change in EVO stock was -.
The NASDAQ listed EVO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Evotec SE designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Enno Spillner
Chief Financial Officer & Member of Management Board
Dr. Ian M. Hunneyball
Senior Vice President of Programme Management & Clinical Operations
Dr. Matthias Evers
Chief Bus. Officer & Member of Management Board
Ms. Monika Conradt
Global Head of HR
Dr. Craig Johnstone
Chief Operating Officer & Member of Management Board
Dr. Werner Lanthaler M.B.A., MBA, MPA, Ph.D.
Chairman of Management Board & Chief Executive Officer
Dr. Cord Dohrmann Ph.D.
Chief Scientific Officer & Member of Management Board
Dr. Craig Johnstone Ph.D.
Chief Operating Officer & Member of Management Board
Dr. Matthias Evers Ph.D.
Chief Bus. Officer & Member of Management Board
Ms. Anja Bosler
Principal Accounting Officer and Senior Vice President of Group Accounting
Mr. Volker Braun
Senior Vice President and Global Head of Investor Relations & ESG
Dr. Christian Dargel
EVice President Global Head of Legal & Compliance
Gabriele Hansen
Senior Vice President & Head of Global Corporation Communications & Marketing
Ms. Laetitia Rouxel
Chief Financial Officer & Member of Management Board
EVO's closing price is 44.91% higher than its 52-week low of $2.85 where as its distance from 52-week high of $8.39 is -50.77%.
Number of EVO employees currently stands at 5,007.
Official Website of EVO is: https://www.evotec.com
EVO could be contacted at phone 494 056 0810 and can also be accessed through its website. EVO operates from Essener Bogen 7, Hamburg, 22419, Germany.
EVO stock volume for the day was 118.68K shares. The average number of EVO shares traded daily for last 3 months was 236.39K.
The market value of EVO currently stands at $1.46B with its latest stock price at $4.13 and 354.61M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com